著者名,論文名,雑誌名,ISSN,出版者名,出版日付,巻,号,ページ,URL,URL(DOI)
Ghassan K. Abou-Alfa and Stephen Lam Chan and Masatoshi Kudo and George Lau and Robin Kate Kelley and Junji Furuse and Wattana Sukeepaisarnjaroen and Yoon-Koo Kang and Tu V. Dao and Enrico N. De Toni and Lorenza Rimassa and Valeriy Vladimirovich Breder and Alexander Vasilyev and Alexandra Heurgue and Vincent Tam and Kabir Mody and Satheesh Chiradoni Thungappa and Philip He and Alejandra Negro and Bruno Sangro,"Phase 3 randomized, open-label, multicenter study of tremelimumab (T) and durvalumab (D) as first-line therapy in patients (pts) with unresectable hepatocellular carcinoma (uHCC): HIMALAYA.",Journal of Clinical Oncology,0732-183X,American Society of Clinical Oncology (ASCO),2022-02-01,40,4_suppl,379-379,https://cir.nii.ac.jp/crid/1360857597123436544,https://doi.org/10.1200/jco.2022.40.4_suppl.379